RUNX1T1 and neoplasm: Several studies have reported that topoisomerase inhibitors, such as ETO, doxorubicin and topotecan, which are commonly used as chemotherapeutic agents, can induce DNA double strand breaks (DSBs) in tumor cells, and these lesions can be toxic to normal cells [37].